Aboderin OA,Abdu AR,Lamikanra A .2009 .Antimicrobial resistance in E. coli strains from UTIs. J. Natl. Med, 101(12) : 1268-1273.
Alnahass R,Khaliel S,Ellakany H,Ibrahim MS H .2016 .Comparison between bacteriological isolation and molecular detection of E. coli from chickens suffering from colibacillosis and/or diarrhea. Alex. J. Vet, 49(2) : 141-148.
Antachopoulos C and Iosifidis E .2017 .Colistin use in neonates and children with infections due to carbapenem-resistant bacteria. Pediatr. Infect. Dis. J., 36(9) : 905-907.
Asthana S,Mathur P,Tak V .2014 .Detection of carbapenemase production in GNR. , 6(2) : 69.
Baran I,Aksu N .2016 .Phenotypic and genotypic characteristics of CRE in a tertiary hospital in Turkey. Microbiol Antimicrob, 15(1) : 20.
Bashir S,Haque A,Sarwar Y,Ali A,Anwar MI .2012 .Virulence profile of different phylogenetic groups of locally isolated community acquired uropathogenic E. coli from Faisalabad region of Pakistan. , 11(1) : 23.
Bello M .2018 .Advances in theoretical studies on the design of single boron atom compounds. Curr. Pharm. Des., 24(29) : 3466-3475.
Bora A,Ahmed G,Hazarika N,Prasad K,Shukla S,Randhawa V,Sarma JB .2013 .Incidence of NDM1 gene in E. coli isolates at a tertiary care referral hospital in Northeast India. Indian J. Med, 31(3) : 250.
Bora A,Sanjana R,Jha BK,Mahaseth SN,Pokharel K SN .2014 .Incidence of MBLs clinical isolates of E. coli and K. pneumoniae in central Nepal. BMC Research Notes, 7(1) : 557.
Bush K,Jacoby GA K .2010 .Updated functional classification of β-lactamases. Antimicrob. Agents and Chemother., 54(3) : 969-976.
Castanheira M,Deshpande LM,Mathai D,Bell JM,Jones RN,Mendes RE .2011 .Early dissemination of NDM1-and OXA-181 of Enterobacteriaceae in Indian hospitals. Antimicrob. Agents and Chemother., 55(3) : 1274-1278.
Griffiths Chen J,M Chen J .1998 .PCR differentiation of E. coli from other Gram negative bacteria using primers derived from the nucleotide sequences flanking the gene encoding the universal stress protein. Lett. Appl, 27(6) : 369-371.
Cusack TP,Ashley EA,Ling CL,Rattanavong S,Roberts T,Turner P,Wangrangsimakul T,Dance DAB .2019 .Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance. Clin. Microbiol, 25(7) : 910-911.
DeLano W .2002 .The PyMOL Molecular Graphics System. , : .
Delma FZ,Al-Hatmi AMS,Buil JB,Lee H,Marlou H,Hoog SDG,Meletiadis J,Verweij PE .2020 .Comparison of MIC test strip and sensititre yeast one with the CLSI and EUCAST broth microdilution reference methods for in vitro antifungal susceptibility testing of cryptococcus neoformans. Antimicrob Agents and Chemother., 64(4) : e02261-19.
Denisuik AJ .2012 .Molecular epidemiology of ESBL, AmpC and MBLs-Ec and K. pneumoniae isolated in Canadian hospitals from. , : .
Deshpande P,Rodrigues C,Shetty A,Kapadia F,Hedge A,Soman R .2010 .NDM-1 in Enterobacteriaceae: Treatment options with carbapenems compromised. J. Assoc. Physicians India, 58 : 147-149.
El Kholy A,Baseem H,Hall GS,Procop GW,Longworth DL .2003 .Antimicrobial resistance in Cairo, Egypt 1999-2000: A survey of five hospitals. J. Antimicrob. Chemother., 51(3) : 625.
Feng H,Liu X,Wang S,Fleming J,Wang DC,Liu W .2017 .The mechanism of NDM-1-catalyzed carbapenem hydrolysis is distinct from that of penicillin or cephalosporin hydrolysis. Nat. Commun, 8(1) : 1-11.
Gebre-Sealsssie S .2007 .Antimicrobial resistance patterns of clinical bacterial isolates in southwestern Ethiopia. Ethiop Med, 45(4) : 363-370.
Guedes IA,de Magalhães CS,Dardenne LE .2014 .Receptor-ligand molecular docking. Biophys. Rev., 6(1) : 75-87.
Holman AM,Allyn J,Miltgen G,Lugagne N,Traversier N,Picot S,Lignereux A,Oudin C,Belmonte O,Allou N O .2017 .December 2015. , 47(5) : 333-339.
Kazmierczak KM,Rabine S,Hackel M,McLaughlin RE,Biedenbach DJ,Bouchillon SK .2016 .Multiyear, multinational survey of the incidence and global distribution of CRE and P. aeruginosa. Antimicrob Agents and Chemother., 60(2) : 1067-1078.
Khajuria A,Praharaj AK,Kumar M,Grover N M .2014 .Emergence of E. coli, co-producing NDM-1 and OXA48, in urinary isolates, at a tertiary care centre at central India. , 8(6) : DC01.
Labute P .2008 .. , 29(10) : 1693-98.
Lascols C,Hackel M,Marshall SH,Hujer AM,Bouchillon S,Badal R,Antimicrob R .2009 .Increasing prevalence and dissemination of NDM-1 MBLs in India: Data from the SMART study (. , 66(9) : 1992-1997.
Leiros HKS,Edvardsen KSW,Bjerga GEK,Samuelsen Ø .2015 .Structural and biochemical characterization of VIM 26 shows that Leu224 has implications for the substrate specificity of VIM metallo‐β‐lactamases. FEBS J, 282(6) : 1031-1042.
Lewell XQ,Judd DB,Watson SP,Hann MM .1998 .RECAP: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J. Chem. Inform. Comput. Sci., 38(3) : 511-522.
Lipinski CA .2004 .Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov. Today Technol, 1(4) : 337-341.
Msolo L,Igbinosa EO,Okoh AI .2016 .Prevalence and antibiogram profiles of E. coli O157: H7 isolates recovered from three selected dairy farms in the Eastern Cape Province, South Africa. Asian Pac. J. Trop. Dis., 6(12) : 990-995.
Mubarak Z,Ali S,Muhammad W,Sabir H,Khan M and Shah F H .2014 .Emergence of CRE in E. coli isolated from different clinical samples. Int. J. Biosci., 4(3) : 74-79.
Nahid F,Khan AA,Rehman S,Zahra R .2013 .Prevalence of NDM-1-producing MDR bacteria at two Pakistani hospitals and implications for public health. J. Infect. Public Health, 6(6) : 487-493.
Nepal K,Pant ND,Neupane B,Belbase A,Baidhya R,Shrestha RK .2017 .ESBL and MBL production among E. coli and K. pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal. , 16(1) : 62.
Pitout JD,Gregson DB,Poirel L,McClure JA,Le P,Church DL .2005 .Detection of P. aeruginosa producing MBLs in a large centralized laboratory. J Clin Microb., 43(7) : 3129-3135.
Poirel L,Walsh TR,Cuvillier V,Nordmann P .2011 .Multiplex PCR for detection of acquired MBL genes. Diagn, 70(1) : 119-123.
Rodríguez-Baño J,Gutiérrez-Gutiérrez B,Machuca I,Pascual A .2018 .Treatment of infections caused by ESBL, AmpC. Clin. Microbiol, 31(2) : e00079-17.
Schrödinger L .2013 .Schrödinger suite 2011 protein preparation wizard. Epik version 2., : .
Shah S .2002 .Susceptibility patterns of Escherichia coli: prevalence of multidrug-resistant isolates and extended spectrum beta-lactamase phenotype. JPMA., 52(407) : .
Shahid M,Sobia F,Singh A,Khan HM,Malik A,Shukla I .2012 .Molecular epidemiology of MBL Enterobacteriaceae from a North Indian Tertiary Hospital. , 66(1) : 5.
Shanthi M,Sekar U,Kamalanathan A,Sekar B .2014 .Detection of NDM-1 in P. aeruginosa in a single centre in southern India. , 140(4) : 546.
Sharma M,Pathak S,Srivastava P .2013 .Prevalence and antibiogram of ESBL producing GNR and further molecular characterization of ESBL-Ec and Klebsiella. , 7(10) : 2173.
Stuart JC,Leverstein-Van MA .2010 .Guideline for phenotypic screening of MBLs in Enterobacteriaceae. Int. J. Antimicrob. Agents., 36(3) : 205-210.
Trojan R,Razdan L,Singh N L .2016 .Antibiogram of bacterial isolates from pus samples in a tertiary care hospital of Punjab, India. Int. J. Microbiol., : .
Ventola CL .2015 .The antibiotic resistance crisis: Part 1: Causes and threats. , 40(4) : 277.
Wadood A,Khan H,Ghufran M,Khan A .2017 .SBD of New and Potent Inhibitors of PIM Kinases. J. Chem. Soc. Pak., 39(1) : 1-10.
Walsh TR,Toleman MA,Poirel L MA .2005 .MBLs: The quiet before the storm? Clin. , 18(2) : 306-325.
Yengkokpam C,Ingudam D,Yengkokpam IS,Jha BK .2007 .Antibiotic susceptibility pattern of urinary isolates in Imphal (Manipur), India. , 9(3) : 170.
Yi F,Li L,Xu LJ,Meng H,Dong YM,Liu HB,Xiao PG .2018 .In silico approach in reveal traditional medicine plants pharmacological material basis. Chin. Med, 13(1) : 33.
Yong D,Toleman MA,Giske CG,Cho HS .2009 .Characterization of NDM-1 and a novel erythromycin esterase gene carried on a unique genetic structure in K. pneumoniae sequence type 14 from India. , 53(12) : 5046-5054.